Omeros (OMER) Capital Expenditures (QoQ) (2010 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Omeros | 772.03 Mn | 636.71 Mn | 9.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -15.38% |
| Jun 30, 2025 | -68.29% |
| Mar 31, 2025 | 57.69% |
| Dec 31, 2024 | 2,500.00% |
| Sep 30, 2024 | -98.75% |
| Jun 30, 2024 | 37.93% |
| Mar 31, 2024 | -50.85% |
| Dec 31, 2023 | 257.58% |
| Sep 30, 2023 | -88.00% |
| Dec 31, 2022 | 533.33% |
| Dec 31, 2021 | -28.16% |
| Sep 30, 2021 | 17.05% |
| Jun 30, 2021 | 633.33% |
| Sep 30, 2020 | -49.31% |
| Jun 30, 2020 | 118.18% |
| Mar 31, 2020 | 312.50% |
| Dec 31, 2019 | -58.97% |
| Sep 30, 2019 | -59.79% |
| Jun 30, 2019 | -46.70% |
| Mar 31, 2019 | 95.70% |
| Dec 31, 2018 | 5.68% |
| Sep 30, 2018 | -56.65% |
| Jun 30, 2018 | 10.93% |
| Sep 30, 2017 | -86.07% |
| Jun 30, 2017 | 238.89% |
| Mar 31, 2017 | 50.00% |
| Dec 31, 2016 | 9.09% |
| Sep 30, 2016 | 29.41% |
| Dec 31, 2015 | -27.40% |
| Sep 30, 2015 | -35.96% |
| Dec 31, 2014 | 60.00% |
| Sep 30, 2014 | 350.00% |
| Jun 30, 2014 | -166.67% |
| Mar 31, 2014 | -91.04% |
| Dec 31, 2013 | 39.58% |
| Sep 30, 2013 | 4,700.00% |
| Jun 30, 2013 | -98.86% |
| Mar 31, 2013 | -78.38% |
| Dec 31, 2012 | 352.22% |
| Sep 30, 2012 | 23.29% |
| Jun 30, 2012 | 1.39% |
| Mar 31, 2012 | 75.61% |
| Dec 31, 2011 | 485.71% |
| Sep 30, 2011 | -98.63% |
| Jun 30, 2011 | -25.07% |
| Mar 31, 2011 | 1,320.83% |
| Dec 31, 2010 | -68.83% |